Ebolavirus: Difference between revisions
CSV import |
CSV import |
||
| Line 29: | Line 29: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Ijms-20-04657-g004.webp|Ebolavirus | |||
File:Ebola virus em.jpg|Ebola virus electron micrograph | |||
File:Filovirus phylogenetic tree.svg|Filovirus phylogenetic tree | |||
File:Filoviridae.|Filoviridae | |||
File:Ebola virus virion.jpg|Ebola virus virion | |||
File:Ebola Virus Particles (44771923695).jpg|Ebola Virus Particles | |||
File:178-EbolaVirusProteins EbolaProteins.png|Ebola Virus Proteins | |||
</gallery> | |||
Revision as of 01:35, 20 February 2025
Ebolavirus is a genus of viruses in the family Filoviridae, Mononegavirales order. It is named after the Ebola River, where the first outbreak of Ebola disease occurred. The viruses are known for causing severe disease in humans and nonhuman primates in the form of viral hemorrhagic fevers.
Overview
Ebolaviruses are single-stranded, negative-sense RNA viruses. The genus contains five species: Zaire ebolavirus, Sudan ebolavirus, Tai Forest ebolavirus, Bundibugyo ebolavirus, and Reston ebolavirus. The first four are known to cause disease in humans, while the Reston species has so far only caused disease in nonhuman primates.
Transmission and symptoms
Ebolaviruses are transmitted through direct contact with blood, body fluids, and tissues of infected persons or wild animals. The incubation period, that is, the time interval from infection with the virus to onset of symptoms, is from 2 to 21 days. Symptoms include fever, fatigue, muscle pain, headache, and sore throat, followed by vomiting, diarrhea, rash, and in some cases, both internal and external bleeding.
Prevention and treatment
Prevention includes reducing the risk of wildlife-to-human transmission and human-to-human transmission. No FDA-approved vaccine or medicine is available for Ebola. Symptoms are treated as they appear, which can improve survival.
See also
References
<references />


